Founders Financial Securities’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.83M | Buy |
7,959
+531
| +7% | +$189K | 0.16% | 130 |
|
|
2025
Q4 | $2.43M | Buy |
7,428
+507
| +7% | +$161K | 0.14% | 141 |
|
|
2025
Q3 | $1.95M | Buy |
6,921
+536
| +8% | +$155K | 0.13% | 155 |
|
|
2025
Q2 | $1.78M | Buy |
6,385
+1,314
| +26% | +$372K | 0.14% | 148 |
|
|
2025
Q1 | $1.44M | Sell |
5,071
-158
| -3% | -$46.7K | 0.12% | 161 |
|
|
2024
Q4 | $1.36M | Buy |
5,229
+186
| +4% | +$55.2K | 0.12% | 148 |
|
|
2024
Q3 | $1.62M | Sell |
5,043
-85
| -2% | -$27.8K | 0.15% | 126 |
|
|
2024
Q2 | $1.6M | Buy |
5,128
+8
| +0.2% | +$2.35K | 0.15% | 128 |
|
|
2024
Q1 | $1.46M | Sell |
5,120
-141
| -3% | -$41.3K | 0.15% | 124 |
|
|
2023
Q4 | $1.52M | Sell |
5,261
-37
| -0.7% | -$10.1K | 0.17% | 114 |
|
|
2023
Q3 | $1.42M | Sell |
5,298
-63
| -1% | -$15.7K | 0.18% | 102 |
|
|
2023
Q2 | $1.19M | Buy |
5,361
+220
| +4% | +$51K | 0.16% | 122 |
|
|
2023
Q1 | $1.24M | Buy |
5,141
+335
| +7% | +$82.2K | 0.18% | 112 |
|
|
2022
Q4 | $1.26M | Sell |
4,806
-346
| -7% | -$92.7K | 0.2% | 111 |
|
|
2022
Q3 | $1.16M | Buy |
5,152
+70
| +1% | +$17K | 0.21% | 102 |
|
|
2022
Q2 | $1.24M | Buy |
5,082
+28
| +0.6% | +$6.86K | 0.24% | 85 |
|
|
2022
Q1 | $1.22M | Buy |
5,054
+450
| +10% | +$103K | 0.22% | 95 |
|
|
2021
Q4 | $1.04M | Buy |
4,604
+197
| +4% | +$41.6K | 0.19% | 104 |
|
|
2021
Q3 | $937K | Sell |
4,407
-1,538
| -26% | -$354K | 0.19% | 109 |
|
|
2021
Q2 | $1.45M | Buy |
5,945
+568
| +11% | +$140K | 0.29% | 77 |
|
|
2021
Q1 | $1.34M | Buy |
5,377
+487
| +10% | +$116K | 0.31% | 63 |
|
|
2020
Q4 | $1.12M | Buy |
+4,890
| New | +$1.13M | 0.27% | 65 |
|
|
2020
Q3 | – | Sell |
-6,339
| Closed | -$1.5M | – | 161 |
|
|
2020
Q2 | $1.5M | Buy |
6,339
+674
| +12% | +$154K | 0.49% | 48 |
|
|
2020
Q1 | $1.15M | Buy |
5,665
+137
| +2% | +$29.9K | 0.43% | 33 |
|
|
2019
Q4 | $1.33M | Sell |
5,528
-17
| -0.3% | -$3.75K | 0.45% | 45 |
|
|
2019
Q3 | $1.07M | Buy |
5,545
+294
| +6% | +$56.4K | 0.34% | 58 |
|
|
2019
Q2 | $968K | Buy |
+5,251
| New | +$940K | 0.32% | 54 |
|
|
2018
Q3 | – | Sell |
-5,788
| Closed | -$1.07M | – | 97 |
|
|
2018
Q2 | $1.07M | Sell |
5,788
-77
| -1% | -$13.6K | 0.33% | 45 |
|
|
2018
Q1 | $1M | Buy |
5,865
+2,234
| +62% | +$410K | 0.32% | 46 |
|
|
2017
Q4 | $631K | Buy |
+3,631
| New | +$643K | 0.21% | 70 |
|
Other funds holding AMGN
VCM
VPM
Founders Financial Securities's AMGN Position: Q1 2026 in Review
Founders Financial Securities increased its Amgen (AMGN) stake by 7.1% in Q1 2026, buying an estimated $189K and bringing the position to 7,959 shares worth $2.83M. The position accounts for 0.16% of the portfolio, ranked #130.
Founders Financial Securities first reported a position in AMGN in Q4 2017 and has held it in 30 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Founders Financial Securities held 7,959 shares of Amgen worth $2.83M as of Q1 2026.
- Founders Financial Securities bought 531 Amgen shares in Q1 2026, an estimated $189K.
- Amgen made up 0.16% of Founders Financial Securities's portfolio in Q1 2026, its #130 holding.
- Founders Financial Securities first reported a position in Amgen in Q4 2017 and has held it in 30 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Founders Financial Securities's 13F filing for Q1 2026, filed 16 Apr 2026.